In VivoThe Asia-Pacific region has historically considered health care sector investment as imperative, yet the COVID-19 pandemic has challenged investment flows in the last few years, resulting in downward
In VivoDevice Transactions The medical device industry raised $1.8 billion in financing during the second quarter of 2015 – nearly double the $934 million amassed in Q1. ( See Exhibit 1. ) The increase is at
In VivoExhibit 1 Top Alliances In June/July 2015 (Potential Deal Value in $M) *Potential deal value is the sum of up-front fees plus pre-commercialization money. SOURCE: Strategic Transactions Exhibit 2 Top